![\"\"](\"https:\/\/www.marketresearch.co.jp\/reports\/wp-content\/uploads\/2025\/04\/output11.png\")
<\/p>\nThe global plant-based vaccines market generated a revenue of US$ 1,691.70 million in 2024 and is projected to expand at a robust CAGR of 11.70%, reaching US$ 3,905.20 million by 2032. This growth reflects increasing global interest in safer, scalable, and cost-effective alternatives to conventional vaccine platforms. Notably, plant-based vaccines accounted for approximately 3.4% of the US$ 38.1 billion recombinant vaccines market in 2024.<\/p>\n
Historically, the market recorded a CAGR of 6.40% from 2019 to 2024. Plant-based vaccines have gained prominence for their ability to stimulate immune responses in humans and animals while addressing limitations seen in traditional vaccine production, particularly regarding storage, cost, and scalability.<\/p>\n
<\/p>\n
Since the concept was first demonstrated in 1998 by the National Institute of Allergy and Infectious Diseases, the use of plants as bioreactors has evolved significantly. Edible vaccines, derived from crops such as maize, tobacco, potatoes, rice, and tomatoes, present a needle-free, cost-effective alternative with simplified logistics.<\/p>\n
Compared to fermentation-based systems, plant-based platforms offer reduced infrastructure costs and streamlined biomass amplification. This makes them particularly attractive for rapid vaccine production in response to emerging health threats.<\/p>\n
Plant-based biologics facilities have the unique advantage of being able to quickly pivot operations for emergency production, which proved critical during the COVID-19 pandemic. These facilities could be instrumental in future global health emergencies, supporting both national preparedness and international aid efforts.<\/p>\n
One of the primary drivers of market growth is the transient expression system, which can produce vaccines in just 20 days after the antigen sequence is identified. This technology offers superior speed and scalability, enabling the production of up to 10 million doses per month.<\/p>\n
Other notable advantages of plant-based vaccines include affordability, safety, and the ability to post-translationally modify proteins, such as through glycosylation, which is not possible in traditional E. coli-based systems. The platform is suitable for a wide array of vaccine types, including multiepitope, subunit, and virus-like particle (VLP) vaccines.<\/p>\n
In stable expression systems, once transgenic plants are established, they can continuously produce vaccine antigens. This is especially beneficial for vaccines in constant demand, offering long-term supply stability and reduced dependency on complex bioreactors.<\/p>\n
Despite its promise, the plant-based vaccine market faces several challenges. Technical limitations in glycosylation and polymerization, the efficiency of recombinant protein expression, and dosage optimization continue to hinder progress. Additionally, chloroplast-based transformation\u2014while beneficial for multi-gene expression\u2014lacks the ability to glycosylate, limiting its utility for certain human vaccines.<\/p>\n
Moreover, a gap exists between laboratory-scale capabilities and full-scale commercialization. Barriers such as limited plant species tested, regulatory uncertainties, and insufficient business and financial frameworks are delaying widespread adoption and market penetration.<\/p>\n
The United States leads the global market with a 37% share in 2024. High levels of R&D investment and the frequent emergence of seasonal pathogens have accelerated the development and deployment of plant-based vaccines in the country.<\/p>\n
Germany held a 5% market share, driven by a high incidence of influenza and growing public health awareness. According to the Robert Koch Institute, over 25,000 deaths were linked to influenza during the 2017\u20132018 flu season, underscoring the need for more effective vaccine solutions.<\/p>\n
Japan, with a 6.6% share in 2024, is poised for substantial growth due to impending regulatory approvals. Clinical trials for a COVID-19 vaccine developed from tobacco plants began in 2021, and local firms are actively working toward commercialization, enhancing the market outlook for the country.<\/p>\n
Viral vaccines represent the dominant product type, comprising 53.2% of the market in 2024. Transgenic plants have proven effective in expressing viral epitopes, leading to vaccines that offer enhanced safety, stability, and immunogenicity compared to traditional methods.<\/p>\n
Influenza remains the largest application segment, holding a 35.9% market share. According to the WHO, seasonal flu causes up to 650,000 deaths annually due to respiratory complications, creating a strong demand for accessible and scalable vaccination options.<\/p>\n
In terms of source, maize is the most utilized plant for vaccine production, accounting for 38.6% of the market. Its suitability for oral delivery and ease of genetic modification make it an attractive option for mass immunization strategies.<\/p>\n
Leading companies are actively pursuing advanced plant expression technologies to reduce development costs and improve production efficiency. Firms are addressing third-generation vaccine challenges by leveraging transgenic and transient platforms that can produce both edible and injectable vaccines for human and animal health.<\/p>\n
Recent developments have shown promising outcomes. In 2022, Canada approved the world\u2019s first plant-derived COVID-19 vaccine. Developed by Medicago Inc., in partnership with Mitsubishi Chemical Holdings and Philip Morris International, the vaccine demonstrated approximately 70% efficacy across multiple variants in a Phase III trial. This milestone underscores the viability of plant-based vaccines on a commercial scale.<\/p>\n
The global plant-based vaccine market is well-positioned for robust expansion over the forecast period, driven by advancements in biotechnology, increasing public and governmental demand for scalable vaccine platforms, and rising health threats. While challenges persist in production efficiency and commercialization pathways, the market is expected to benefit from continued innovation, strategic collaborations, and evolving regulatory support.<\/p>\n
Manufacturers focusing on rapid-response vaccine platforms, edible formulations, and cost-reduction strategies are likely to gain a competitive edge. As more countries recognize the strategic value of plant-based systems, significant investment opportunities and partnerships are anticipated in the coming years.<\/p>\n
\n
1. Executive Summary<\/strong><\/p>\n 1.1. Global Market Outlook<\/p>\n 1.2. Demand Side Trends<\/p>\n 1.3. Supply Side Trends<\/p>\n 1.4. Analysis and Recommendations<\/p>\n 2. Market Overview<\/strong><\/p>\n 2.1. Market Coverage \/ Taxonomy<\/p>\n 2.2. Market Definition \/ Scope \/ Limitations<\/p>\n 2.3. Inclusions and Exclusions<\/p>\n 3. Key Market Trends<\/strong><\/p>\n 3.1. Key Trends Impacting the Market<\/p>\n 3.2. Market Innovation \/ Development Trends<\/p>\n 4. Key Success Factors<\/strong><\/p>\n 4.1. Promotional Strategies, By Key Manufacturers<\/p>\n 4.2. Key Regulations<\/p>\n 4.3. Product Pipeline<\/p>\n 4.4. Reimbursement Scenario<\/p>\n 4.5. Value Chain Analysis<\/p>\n 4.6. PESTEL Analysis<\/p>\n 4.7. Porter\u2019s Analysis<\/p>\n 5. Market Background<\/strong><\/p>\n 5.1. Macro-Economic Factors<\/p>\n 5.1.1. Global GDP Growth Outlook<\/p>\n 5.1.2. Global Healthcare Expenditure Outlook<\/p>\n 5.1.3. Global Recombinant Vaccines Market Outlook<\/p>\n 5.2. Forecast Factors – Relevance & Impact<\/p>\n 5.2.1. Cost of Production<\/p>\n 5.2.2. Growing Development of Recombinant Vaccines<\/p>\n 5.2.3. Increasing Incidence of Zoonotic Diseases<\/p>\n 5.2.4. Rising Research and Development Activities<\/p>\n 5.2.5. Growing Marketing Approvals for Plant-Based Vaccines<\/p>\n 5.2.6. Cost of Vaccines<\/p>\n 5.2.7. Emergence of the COVID-19 Pandemic<\/p>\n 5.2.8. Large Clinical Pipeline<\/p>\n 5.3. Market Dynamics<\/p>\n 5.3.1. Drivers<\/p>\n 5.3.2. Restraints<\/p>\n 5.3.3. Opportunity Analysis<\/p>\n 6. COVID-19 Crisis Analysis<\/strong><\/p>\n 6.1. COVID-19 and Impact Analysis<\/p>\n 6.1.1. By Source<\/p>\n 6.1.2. By Type<\/p>\n 6.1.3. By Application<\/p>\n 6.1.4. By Country<\/p>\n 6.2. 2021 Market Scenario<\/p>\n 7. Global Plant-Based Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032<\/strong><\/p>\n 7.1. Historical Market Value (US$ Mn) Analysis, 2019 – 2032<\/p>\n 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032<\/p>\n 7.2.1. Y-o-Y Growth Trend Analysis<\/p>\n 7.2.2. Absolute $ Opportunity Analysis<\/p>\n 8. Global Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032, By Source<\/strong><\/p>\n 8.1. Introduction \/ Key Findings<\/p>\n 8.2. Historical Market Size (US$ Mn) Analysis By Source, 2012 – 2021<\/p>\n 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2022 – 2032<\/p>\n 8.3.1. Maize<\/p>\n 8.3.2. Tobacco<\/p>\n 8.3.3. Potato<\/p>\n 8.3.4. Others<\/p>\n 8.4. Market Attractiveness Analysis By Source<\/p>\n 9. Global Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032, By Type<\/strong><\/p>\n 9.1. Introduction \/ Key Findings<\/p>\n 9.2. Historical Market Size (US$ Mn) Analysis By Type , 2012 – 2021<\/p>\n 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2022 – 2032<\/p>\n 9.3.1. Viral Vaccine<\/p>\n 9.3.2. Bacterial Vaccine<\/p>\n 9.3.3. Others<\/p>\n 9.4. Market Attractiveness Analysis By Type<\/p>\n 10. Global Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032, By Application<\/strong><\/p>\n 10.1. Introduction \/ Key Findings<\/p>\n 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2012 – 2021<\/p>\n 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022 – 2032<\/p>\n 10.3.1. Influenza<\/p>\n 10.3.2. Zika Virus<\/p>\n 10.3.3. Ebola Virus<\/p>\n 10.3.4. Others<\/p>\n 10.4. Market Attractiveness Analysis By Application<\/p>\n 11. Global Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032, By Region<\/strong><\/p>\n 11.1. Introduction \/ Key Findings<\/p>\n 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019 – 2032<\/p>\n 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2032<\/p>\n 11.3.1. North America<\/p>\n 11.3.2. Latin America<\/p>\n 11.3.3. Europe<\/p>\n 11.3.4. East Asia<\/p>\n 11.3.5. South Asia<\/p>\n 11.3.6. Oceania<\/p>\n 11.3.7. Middle East and Africa<\/p>\n 11.4. Market Attractiveness Analysis By Region<\/p>\n 12. North America Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032<\/strong><\/p>\n 12.1. Introduction<\/p>\n 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 – 2032<\/p>\n 12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2032<\/p>\n 12.3.1. By Country<\/p>\n 12.3.1.1. U.S.<\/p>\n 12.3.1.2. Canada<\/p>\n 12.3.2. By Source<\/p>\n 12.3.3. By Type<\/p>\n 12.3.4. By Application<\/p>\n 12.4. Market Attractiveness Analysis<\/p>\n 12.4.1. By Country<\/p>\n 12.4.2. By Source<\/p>\n 12.4.3. By Type<\/p>\n 12.4.4. By Application<\/p>\n 12.5. Market Trends<\/p>\n 12.6. Key Market Participants – Intensity Mapping<\/p>\n 12.7. Drivers and Restraints – Impact Analysis<\/p>\n 12.8. Country Level Analysis & Forecast<\/p>\n 12.8.1. U.S. Plant-Based Vaccines Market Analysis<\/p>\n 12.8.1.1. Introduction<\/p>\n 12.8.1.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 12.8.1.2.1. By Country<\/p>\n 12.8.1.2.2. By Source<\/p>\n 12.8.1.2.3. By Type<\/p>\n 12.8.1.2.4. By Application<\/p>\n 12.8.2. Canada Plant-Based Vaccines Market Analysis<\/p>\n 12.8.2.1. Introduction<\/p>\n 12.8.2.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 12.8.2.2.1. By Country<\/p>\n 12.8.2.2.2. By Source<\/p>\n 12.8.2.2.3. By Type<\/p>\n 12.8.2.2.4. By Application<\/p>\n 13. Latin America Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032<\/strong><\/p>\n 13.1. Introduction<\/p>\n 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 – 2032<\/p>\n 13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2032<\/p>\n 13.3.1. By Country<\/p>\n 13.3.1.1. Mexico<\/p>\n 13.3.1.2. Brazil<\/p>\n 13.3.1.3. Argentina<\/p>\n 13.3.1.4. Rest of Latin America<\/p>\n 13.3.1.4.1. By Country<\/p>\n 13.3.1.4.2. By Source<\/p>\n 13.3.1.4.3. By Type<\/p>\n 13.3.1.4.4. By Application<\/p>\n 13.4. Market Attractiveness Analysis<\/p>\n 13.4.1. By Country<\/p>\n 13.4.2. By Source<\/p>\n 13.4.3. By Type<\/p>\n 13.4.4. By Application<\/p>\n 13.5. Market Trends<\/p>\n 13.6. Key Market Participants – Intensity Mapping<\/p>\n 13.7. Drivers and Restraints – Impact Analysis<\/p>\n 13.8. Country Level Analysis & Forecast<\/p>\n 13.8.1. Mexico Plant-Based Vaccines Market Analysis<\/p>\n 13.8.1.1. Introduction<\/p>\n 13.8.1.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 13.8.1.2.1. By Source<\/p>\n 13.8.1.2.2. By Type<\/p>\n 13.8.1.2.3. By Application<\/p>\n 13.8.2. Brazil Plant-Based Vaccines Market Analysis<\/p>\n 13.8.2.1. Introduction<\/p>\n 13.8.2.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 13.8.2.2.1. By Country<\/p>\n 13.8.2.2.2. By Source<\/p>\n 13.8.2.2.3. By Type<\/p>\n 13.8.2.2.4. By Application<\/p>\n 13.8.3. Argentina Plant-Based Vaccines Market Analysis<\/p>\n 13.8.3.1. Introduction<\/p>\n 13.8.3.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 13.8.3.2.1. By Source<\/p>\n 13.8.3.2.2. By Type<\/p>\n 13.8.3.2.3. By Application<\/p>\n 14. Europe Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032<\/strong><\/p>\n 14.1. Introduction<\/p>\n 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 – 2032<\/p>\n 14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2032<\/p>\n 14.3.1. By Country<\/p>\n 14.3.1.1. Germany<\/p>\n 14.3.1.2. Italy<\/p>\n 14.3.1.3. France<\/p>\n 14.3.1.4. U.K.<\/p>\n 14.3.1.5. Spain<\/p>\n 14.3.1.6. BENELUX<\/p>\n 14.3.1.7. Russia<\/p>\n 14.3.1.8. Rest of Europe<\/p>\n 14.3.2. By Source<\/p>\n 14.3.3. By Type<\/p>\n 14.3.4. By Application<\/p>\n 14.4. Market Attractiveness Analysis<\/p>\n 14.4.1. By Country<\/p>\n 14.4.2. By Source<\/p>\n 14.4.3. By Type<\/p>\n 14.4.4. By Application<\/p>\n 14.5. Market Trends<\/p>\n 14.6. Key Market Participants – Intensity Mapping<\/p>\n 14.7. Drivers and Restraints – Impact Analysis<\/p>\n 14.8. Country Level Analysis & Forecast<\/p>\n 14.8.1. Germany Plant-Based Vaccines Market Analysis<\/p>\n 14.8.1.1. Introduction<\/p>\n 14.8.1.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 14.8.1.2.1. By Source<\/p>\n 14.8.1.2.2. By Type<\/p>\n 14.8.1.2.3. By Application<\/p>\n 14.8.2. Italy Plant-Based Vaccines Market Analysis<\/p>\n 14.8.2.1. Introduction<\/p>\n 14.8.2.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 14.8.2.2.1. By Source<\/p>\n 14.8.2.2.2. By Type<\/p>\n 14.8.2.2.3. By Application<\/p>\n 14.8.3. France Plant-Based Vaccines Market Analysis<\/p>\n 14.8.3.1. Introduction<\/p>\n 14.8.3.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 14.8.3.2.1. By Source<\/p>\n 14.8.3.2.2. By Type<\/p>\n 14.8.3.2.3. By Application<\/p>\n 14.8.4. U.K. Plant-Based Vaccines Market Analysis<\/p>\n 14.8.4.1. Introduction<\/p>\n 14.8.4.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 14.8.4.2.1. By Source<\/p>\n 14.8.4.2.2. By Type<\/p>\n 14.8.4.2.3. By Application<\/p>\n 14.8.5. Spain Plant-Based Vaccines Market Analysis<\/p>\n 14.8.5.1. Introduction<\/p>\n 14.8.5.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 14.8.5.2.1. By Source<\/p>\n 14.8.5.2.2. By Type<\/p>\n 14.8.5.2.3. By Application<\/p>\n 14.8.6. BENELUX Plant-Based Vaccines Market Analysis<\/p>\n 14.8.6.1. Introduction<\/p>\n 14.8.6.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 14.8.6.2.1. By Source<\/p>\n 14.8.6.2.2. By Type<\/p>\n 14.8.6.2.3. By Application<\/p>\n 14.8.7. Russia Plant-Based Vaccines Market Analysis<\/p>\n 14.8.7.1. Introduction<\/p>\n 14.8.7.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 14.8.7.2.1. By Source<\/p>\n 14.8.7.2.2. By Type<\/p>\n 14.8.7.2.3. By Application<\/p>\n 15. East Asia Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032<\/strong><\/p>\n 15.1. Introduction<\/p>\n 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 – 2032<\/p>\n 15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2032<\/p>\n 15.3.1. By Country<\/p>\n 15.3.1.1. China<\/p>\n 15.3.1.2. Japan<\/p>\n 15.3.1.3. South Korea<\/p>\n 15.3.2. By Source<\/p>\n 15.3.3. By Type<\/p>\n 15.3.4. By Application<\/p>\n 15.4. Market Attractiveness Analysis<\/p>\n 15.4.1. By Country<\/p>\n 15.4.2. By Source<\/p>\n 15.4.3. By Type<\/p>\n 15.4.4. By Application<\/p>\n 15.5. Market Trends<\/p>\n 15.6. Key Market Participants – Intensity Mapping<\/p>\n 15.7. Drivers and Restraints – Impact Analysis<\/p>\n 15.8. Country Level Analysis & Forecast<\/p>\n 15.8.1. China Plant-Based Vaccines Market Analysis<\/p>\n 15.8.1.1. Introduction<\/p>\n 15.8.1.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 15.8.1.2.1. By Source<\/p>\n 15.8.1.2.2. By Type<\/p>\n 15.8.1.2.3. By Application<\/p>\n 15.8.2. Japan Plant-Based Vaccines Market Analysis<\/p>\n 15.8.2.1. Introduction<\/p>\n 15.8.2.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 15.8.2.2.1. By Source<\/p>\n 15.8.2.2.2. By Type<\/p>\n 15.8.2.2.3. By Application<\/p>\n 15.8.3. South Korea Plant-Based Vaccines Market Analysis<\/p>\n 15.8.3.1. Introduction<\/p>\n 15.8.3.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 15.8.3.2.1. By Source<\/p>\n 15.8.3.2.2. By Type<\/p>\n 15.8.3.2.3. By Application<\/p>\n 16. South Asia Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032<\/strong><\/p>\n 16.1. Introduction<\/p>\n 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 – 2032<\/p>\n 16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2032<\/p>\n 16.3.1. By Country<\/p>\n 16.3.1.1. India<\/p>\n 16.3.1.2. Indonesia<\/p>\n 16.3.1.3. Malaysia<\/p>\n 16.3.1.4. Thailand<\/p>\n 16.3.1.5. Rest of South Asia<\/p>\n 16.3.2. By Source<\/p>\n 16.3.3. By Type<\/p>\n 16.3.4. By Application<\/p>\n 16.4. Market Attractiveness Analysis<\/p>\n 16.4.1. By Country<\/p>\n 16.4.2. By Source<\/p>\n 16.4.3. By Type<\/p>\n 16.4.4. By Application<\/p>\n 16.5. Market Trends<\/p>\n 16.6. Key Market Participants – Intensity Mapping<\/p>\n 16.7. Drivers and Restraints – Impact Analysis<\/p>\n 16.8. Country Level Analysis & Forecast<\/p>\n 16.8.1. India Plant-Based Vaccines Market Analysis<\/p>\n 16.8.1.1. Introduction<\/p>\n 16.8.1.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 16.8.1.2.1. By Source<\/p>\n 16.8.1.2.2. By Type<\/p>\n 16.8.1.2.3. By Application<\/p>\n 16.8.2. Indonesia Plant-Based Vaccines Market Analysis<\/p>\n 16.8.2.1. Introduction<\/p>\n 16.8.2.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 16.8.2.2.1. By Source<\/p>\n 16.8.2.2.2. By Type<\/p>\n 16.8.2.2.3. By Application<\/p>\n 16.8.3. Malaysia Plant-Based Vaccines Market Analysis<\/p>\n 16.8.3.1. Introduction<\/p>\n 16.8.3.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 16.8.3.2.1. By Source<\/p>\n 16.8.3.2.2. By Type<\/p>\n 16.8.3.2.3. By Application<\/p>\n 16.8.4. Thailand Plant-Based Vaccines Market Analysis<\/p>\n 16.8.4.1. Introduction<\/p>\n 16.8.4.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 16.8.4.2.1. By Source<\/p>\n 16.8.4.2.2. By Type<\/p>\n 16.8.4.2.3. By Application<\/p>\n 17. Oceania Plant-Based Vaccines Market 2019-2023 and Forecast 2024-2032<\/strong><\/p>\n 17.1. Introduction<\/p>\n 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 – 2032<\/p>\n 17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2032<\/p>\n 17.3.1. By Country<\/p>\n 17.3.1.1. Australia<\/p>\n 17.3.1.2. New Zealand<\/p>\n 17.3.2. By Source<\/p>\n 17.3.3. By Type<\/p>\n 17.3.4. By Application<\/p>\n 17.4. Market Attractiveness Analysis<\/p>\n 17.4.1. By Country<\/p>\n 17.4.2. By Source<\/p>\n 17.4.3. By Type<\/p>\n 17.4.4. By Application<\/p>\n 17.5. Key Market Participants – Intensity Mapping<\/p>\n 17.6. Drivers and Restraints – Impact Analysis<\/p>\n 17.7. Country Level Analysis & Forecast<\/p>\n 17.7.1. Australia Plant-Based Vaccines Market Analysis<\/p>\n 17.7.1.1. Introduction<\/p>\n 17.7.1.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 17.7.1.2.1. By Source<\/p>\n 17.7.1.2.2. By Type<\/p>\n 17.7.1.2.3. By Application<\/p>\n 17.7.2. New Zealand Plant-Based Vaccines Market Analysis<\/p>\n 17.7.2.1. Introduction<\/p>\n 17.7.2.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 17.7.2.2.1. By Source<\/p>\n 17.7.2.2.2. By Type<\/p>\n 17.7.2.2.3. By Application<\/p>\n 18. Middle East and Africa (MEA) Plant-Based Vaccines Market Analysis 2019-2023 and Forecast 2024-2032<\/strong><\/p>\n 18.1. Introduction<\/p>\n 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019 – 2032<\/p>\n 18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2032<\/p>\n 18.3.1. By Country<\/p>\n 18.3.1.1. GCC Countries<\/p>\n 18.3.1.2. Turkey<\/p>\n 18.3.1.3. South Africa<\/p>\n 18.3.1.4. \u00a0North Africa<\/p>\n 18.3.1.5. Rest of Middle East and Africa<\/p>\n 18.3.2. By Source<\/p>\n 18.3.3. By Type<\/p>\n 18.3.4. By Application<\/p>\n 18.4. Market Attractiveness Analysis<\/p>\n 18.4.1. By Country<\/p>\n 18.4.2. By Source<\/p>\n 18.4.3. By Type<\/p>\n 18.4.4. By Application<\/p>\n 18.5. Market Trends<\/p>\n 18.6. Key Market Participants – Intensity Mapping<\/p>\n 18.7. Drivers and Restraints – Impact Analysis<\/p>\n 18.8. Country Level Analysis & Forecast<\/p>\n 18.8.1. GCC Countries Plant-Based Vaccines Market Analysis<\/p>\n 18.8.1.1. Introduction<\/p>\n 18.8.1.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 18.8.1.2.1. By Source<\/p>\n 18.8.1.2.2. By Type<\/p>\n 18.8.1.2.3. By Application<\/p>\n 18.8.2. Turkey Plant-Based Vaccines Market Analysis<\/p>\n 18.8.2.1. Introduction<\/p>\n 18.8.2.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 18.8.2.2.1. By Source<\/p>\n 18.8.2.2.2. By Type<\/p>\n 18.8.2.2.3. By Application<\/p>\n 18.8.3. South Africa Plant-Based Vaccines Market Analysis<\/p>\n 18.8.3.1. Introduction<\/p>\n 18.8.3.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 18.8.3.2.1. By Source<\/p>\n 18.8.3.2.2. By Type<\/p>\n 18.8.3.2.3. By Application<\/p>\n 18.8.4. North Africa Plant-Based Vaccines Market Analysis<\/p>\n 18.8.4.1. Introduction<\/p>\n 18.8.4.2. Market Analysis and Forecast By Market Taxonomy<\/p>\n 18.8.4.2.1. By Source<\/p>\n 18.8.4.2.2. By Type<\/p>\n 18.8.4.2.3. By Application<\/p>\n 19. Market Structure Analysis<\/strong><\/p>\n 19.1. Market Analysis By Tier of Companies<\/p>\n 19.2. Market Concentration<\/p>\n 19.3. Market Share Analysis (%) of Top Players<\/p>\n 19.4. Market Presence Analysis<\/p>\n 20. Competition Analysis<\/strong><\/p>\n 20.1. Competition Dashboard<\/p>\n 20.2. Competition Benchmarking<\/p>\n 20.3. Competition Deep Dive<\/p>\n 20.3.1.\u00a0Creative Biolabs<\/strong><\/p>\n 20.3.1.1. Overview<\/p>\n 20.3.1.2. Product Portfolio<\/p>\n 20.3.1.3. Sales Footprint<\/p>\n 20.3.1.4. Key Financials<\/p>\n 20.3.1.5. SWOT Analysis<\/p>\n 20.3.1.6. Strategic Overview<\/p>\n 20.3.2.\u00a0Medicago Inc.<\/strong><\/p>\n 20.3.2.1. Overview<\/p>\n 20.3.2.2. Product Portfolio<\/p>\n 20.3.2.3. Sales Footprint<\/p>\n 20.3.2.4. Key Financials<\/p>\n 20.3.2.5. SWOT Analysis<\/p>\n 20.3.2.6. Strategic Overview<\/p>\n 20.3.3.\u00a0iBio<\/strong><\/p>\n 20.3.3.1. Overview<\/p>\n 20.3.3.2. Product Portfolio<\/p>\n 20.3.3.3. Sales Footprint<\/p>\n 20.3.3.4. Key Financials<\/p>\n 20.3.3.5. SWOT Analysis<\/p>\n 20.3.3.6. Strategic Overview<\/p>\n 20.3.4.\u00a0ICON<\/strong><\/p>\n 20.3.4.1. Overview<\/p>\n 20.3.4.2. Product Portfolio<\/p>\n 20.3.4.3. Sales Footprint<\/p>\n 20.3.4.4. Key Financials<\/p>\n 20.3.4.5. SWOT Analysis<\/p>\n 20.3.4.6. Strategic Overview<\/p>\n 20.3.5.\u00a0EEA Consulting Engineers<\/strong><\/p>\n 20.3.5.1. Overview<\/p>\n 20.3.5.2. Product Portfolio<\/p>\n 20.3.5.3. Sales Footprint<\/p>\n 20.3.5.4. Key Financials<\/p>\n 20.3.5.5. SWOT Analysis<\/p>\n 20.3.5.6. Strategic Overview<\/p>\n 20.3.6.\u00a0Kentucky BioProcessing, Inc.<\/strong><\/p>\n 20.3.6.1. Overview<\/p>\n 20.3.6.2. Product Portfolio<\/p>\n 20.3.6.3. Sales Footprint<\/p>\n 20.3.6.4. Key Financials<\/p>\n 20.3.6.5. SWOT Analysis<\/p>\n 20.3.6.6. Strategic Overview<\/p>\n 20.3.7.\u00a0Baiya Phytopharm<\/strong><\/p>\n 20.3.7.1. Overview<\/p>\n 20.3.7.2. Product Portfolio<\/p>\n 20.3.7.3. Sales Footprint<\/p>\n 20.3.7.4. Key Financials<\/p>\n 20.3.7.5. SWOT Analysis<\/p>\n 20.3.7.6. Strategic Overview<\/p>\n 20.3.8.\u00a0Protalix Biotherapeutics<\/strong><\/p>\n 20.3.8.1. Overview<\/p>\n 20.3.8.2. Product Portfolio<\/p>\n 20.3.8.3. Sales Footprint<\/p>\n 20.3.8.4. Key Financials<\/p>\n 20.3.8.5. SWOT Analysis<\/p>\n 20.3.8.6. Strategic Overview<\/p>\n 21. Assumptions and Acronyms Used<\/strong><\/p>\n 22. Research Methodology<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":" Market Overview The global plant-based vaccines market generated a revenue of US$ 1,691.70 million in 2024 and is projected to expand at a robust CAGR of 11.70%, reaching US$ 3,905.20 million by 2032. This growth reflects increasing global interest in safer, scalable, and cost-effective alternatives to conventional vaccine platforms. Notably, plant-based vaccines accounted for approximately… Global Plant-based Vaccines Market Size, Share, and Growth Forecast for 2025 – 2032<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[3,4],"tags":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/posts\/30"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/comments?post=30"}],"version-history":[{"count":0,"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/posts\/30\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/media?parent=30"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/categories?post=30"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/reports\/wp-json\/wp\/v2\/tags?post=30"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}